表紙
市場調查報告書
商品編碼
1087337

旅遊用疫苗的全球市場:2022年∼2026年

Global Travel Vaccines Market 2022-2026

出版日期: | 出版商: TechNavio (Infiniti Research Ltd.) | 英文 120 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球旅遊用疫苗的市場規模在2022年∼2026年間,預測將成長到24億4,000萬美元,在預測期間中預計將以8.59%的年複合成長率增長。

市場成長的主要因素有全球性移民人數的增加、旅行者對疫苗可預防疾病的認識提高以及國家在簽證簽發前接種疫苗的規定等。

本報告涵括旅遊用疫苗的全球市場的整體分析,提供市場規模與預測,趨勢,成長促進因素,課題,及約25供應商的分析。

目錄

第1章 摘要整理

  • 市場概要

第2章 市場形勢

  • 市場生態系統

第3章 市場規模

  • 市場定義
  • 市場區隔分析
  • 2021年的市場規模
  • 市場預測:從2021年∼2026年的預測

第4章 波特的五力分析

  • 五力彙整
  • 買方議價能力
  • 供給企業談判力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情況

第5章 市場區隔:各疾病類型

  • 市場區隔
  • 各疾病種類的比較
  • 流感:市場規模與預測(2021年∼2026年)
  • 白喉:市場規模與預測(2021年∼2026年)
  • 肝炎:市場規模與預測(2021年∼2026年)
  • 其他:市場規模與預測(2021年∼2026年)
  • 各疾病類型的市場機會

第6章 客戶形勢

  • 客戶形勢概要

第7章 各地區形勢

  • 各地區市場區隔
  • 各地區的比較
  • 北美:市場規模與預測(2021年∼2026年)
  • 歐洲:市場規模與預測(2021年∼2026年)
  • 亞洲:市場規模與預測(2021年∼2026年)
  • 其他地區:市場規模與預測(2021年∼2026年)
  • 美國:市場規模與預測(2021年∼2026年)
  • 德國:市場規模與預測(2021年∼2026年)
  • 英國:市場規模與預測(2021年∼2026年)
  • 日本:市場規模與預測(2021年∼2026年)
  • 中國:市場規模與預測(2021年∼2026年)
  • 各地區形勢的市場機會

第8章 推動要素,課題,及趨勢

  • 市場推動要素
  • 市場課題
  • 推動要素與課題的影響
  • 市場趨勢

第9章 業者情勢

  • 概要
  • 業者情勢
  • 混亂狀況
  • 產業的風險

第10章 供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Bharat Biotech Ltd.
  • CSL Ltd.
  • GlaxoSmithKline Plc
  • Merck and Co. Inc.
  • Mitsubishi Chemical Holdings Corp.
  • Pfizer Inc.
  • Sanofi
  • Serum Institute of India Pvt. Ltd.
  • SK Chemicals Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd.

第11章 附錄

目錄
Product Code: IRTNTR70539

Technavio has been monitoring the travel vaccines market and it is poised to grow by $ 2.44 billion during 2022-2026, accelerating at a CAGR of 8.59% during the forecast period. Our report on the travel vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in global migration, increase in awareness about vaccine-preventable diseases among travelers, and mandates by countries on vaccinations prior to issuing visas.

The travel vaccines market analysis includes the disease type segment and geographic landscape.

Technavio's travel vaccines market is segmented as below:

By Disease Type

  • Influenza
  • Diptheria
  • Hepatitis
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the changes in the demographic profile of travelers globally as one of the prime reasons driving the travel vaccines market growth during the next few years. Also, increased incidence of travel-related diseases and initiatives by governments and other organizations to ensure travel safety will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on travel vaccines market covers the following areas:

  • Travel vaccines market sizing
  • Travel vaccines market forecast
  • Travel vaccines market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading travel vaccines market vendors that include Abbott Laboratories, Altimmune Inc., AstraZeneca Plc, Bharat Biotech Ltd., CSL Ltd., Dynavax Technologies Corp., Emergent BioSolutions Inc., GlaxoSmithKline Plc, KM Biologics Co. Ltd., LG Chem Ltd., Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Sinovac Biotech Ltd., SK Chemicals Co. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE. Also, the travel vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Disease Type

  • 5.1 Market segments
  • Exhibit 24: Chart on Disease Type - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Disease Type - Market share 2021-2026 (%)
  • 5.2 Comparison by Disease Type
  • Exhibit 26: Chart on Comparison by Disease Type
  • Exhibit 27: Data Table on Comparison by Disease Type
  • 5.3 Influenza - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Influenza - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Influenza - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Influenza - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Influenza - Year-over-year growth 2021-2026 (%)
  • 5.4 Diptheria - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Diptheria - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Diptheria - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Diptheria - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Diptheria - Year-over-year growth 2021-2026 (%)
  • 5.5 Hepatitis - Market size and forecast 2021-2026
  • Exhibit 36: Chart on Hepatitis - Market size and forecast 2021-2026 ($ million)
  • Exhibit 37: Data Table on Hepatitis - Market size and forecast 2021-2026 ($ million)
  • Exhibit 38: Chart on Hepatitis - Year-over-year growth 2021-2026 (%)
  • Exhibit 39: Data Table on Hepatitis - Year-over-year growth 2021-2026 (%)
  • 5.6 Others - Market size and forecast 2021-2026
  • Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
  • Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
  • 5.7 Market opportunity by Disease Type
  • Exhibit 44: Market opportunity by Disease Type ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 48: Chart on Geographic comparison
  • Exhibit 49: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Germany - Market size and forecast 2021-2026
  • Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.9 UK - Market size and forecast 2021-2026
  • Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.10 Japan - Market size and forecast 2021-2026
  • Exhibit 78: Chart on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibit 79: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibit 80: Chart on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibit 81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
  • 7.11 China - Market size and forecast 2021-2026
  • Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 86: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 87: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 89: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 90: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 91: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 92: Matrix on vendor position and classification
  • 10.3 Bharat Biotech Ltd.
  • Exhibit 93: Bharat Biotech Ltd. - Overview
  • Exhibit 94: Bharat Biotech Ltd. - Product / Service
  • Exhibit 95: Bharat Biotech Ltd. - Key news
  • Exhibit 96: Bharat Biotech Ltd. - Key offerings
  • 10.4 CSL Ltd.
  • Exhibit 97: CSL Ltd. - Overview
  • Exhibit 98: CSL Ltd. - Business segments
  • Exhibit 99: CSL Ltd. - Key news
  • Exhibit 100: CSL Ltd. - Key offerings
  • Exhibit 101: CSL Ltd. - Segment focus
  • 10.5 GlaxoSmithKline Plc
  • Exhibit 102: GlaxoSmithKline Plc - Overview
  • Exhibit 103: GlaxoSmithKline Plc - Business segments
  • Exhibit 104: GlaxoSmithKline Plc - Key news
  • Exhibit 105: GlaxoSmithKline Plc - Key offerings
  • Exhibit 106: GlaxoSmithKline Plc - Segment focus
  • 10.6 Merck and Co. Inc.
  • Exhibit 107: Merck and Co. Inc. - Overview
  • Exhibit 108: Merck and Co. Inc. - Business segments
  • Exhibit 109: Merck and Co. Inc. - Key news
  • Exhibit 110: Merck and Co. Inc. - Key offerings
  • Exhibit 111: Merck and Co. Inc. - Segment focus
  • 10.7 Mitsubishi Chemical Holdings Corp.
  • Exhibit 112: Mitsubishi Chemical Holdings Corp. - Overview
  • Exhibit 113: Mitsubishi Chemical Holdings Corp. - Business segments
  • Exhibit 114: Mitsubishi Chemical Holdings Corp. - Key offerings
  • Exhibit 115: Mitsubishi Chemical Holdings Corp. - Segment focus
  • 10.8 Pfizer Inc.
  • Exhibit 116: Pfizer Inc. - Overview
  • Exhibit 117: Pfizer Inc. - Product / Service
  • Exhibit 118: Pfizer Inc. - Key news
  • Exhibit 119: Pfizer Inc. - Key offerings
  • 10.9 Sanofi
  • Exhibit 120: Sanofi - Overview
  • Exhibit 121: Sanofi - Business segments
  • Exhibit 122: Sanofi - Key news
  • Exhibit 123: Sanofi - Key offerings
  • Exhibit 124: Sanofi - Segment focus
  • 10.10 Serum Institute of India Pvt. Ltd.
  • Exhibit 125: Serum Institute of India Pvt. Ltd. - Overview
  • Exhibit 126: Serum Institute of India Pvt. Ltd. - Product / Service
  • Exhibit 127: Serum Institute of India Pvt. Ltd. - Key offerings
  • 10.11 SK Chemicals Co. Ltd.
  • Exhibit 128: SK Chemicals Co. Ltd. - Overview
  • Exhibit 129: SK Chemicals Co. Ltd. - Business segments
  • Exhibit 130: SK Chemicals Co. Ltd. - Key offerings
  • Exhibit 131: SK Chemicals Co. Ltd. - Segment focus
  • 10.12 Takeda Pharmaceutical Co. Ltd.
  • Exhibit 132: Takeda Pharmaceutical Co. Ltd. - Overview
  • Exhibit 133: Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Exhibit 134: Takeda Pharmaceutical Co. Ltd. - Key news
  • Exhibit 135: Takeda Pharmaceutical Co. Ltd. - Key offerings

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 136: Inclusions checklist
  • Exhibit 137: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 138: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 139: Research methodology
  • Exhibit 140: Validation techniques employed for market sizing
  • Exhibit 141: Information sources
  • 11.5 List of abbreviations
  • Exhibit 142: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Disease Type - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Disease Type - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Disease Type
  • Exhibits27: Data Table on Comparison by Disease Type
  • Exhibits28: Chart on Influenza - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on Influenza - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on Influenza - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Influenza - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Diptheria - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Diptheria - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Diptheria - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Diptheria - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Chart on Hepatitis - Market size and forecast 2021-2026 ($ million)
  • Exhibits37: Data Table on Hepatitis - Market size and forecast 2021-2026 ($ million)
  • Exhibits38: Chart on Hepatitis - Year-over-year growth 2021-2026 (%)
  • Exhibits39: Data Table on Hepatitis - Year-over-year growth 2021-2026 (%)
  • Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
  • Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
  • Exhibits44: Market opportunity by Disease Type ($ million)
  • Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits48: Chart on Geographic comparison
  • Exhibits49: Data Table on Geographic comparison
  • Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Chart on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibits79: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibits80: Chart on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibits81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibits82: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits83: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits84: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits85: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits86: Market opportunity By Geographical Landscape ($ million)
  • Exhibits87: Impact of drivers and challenges in 2021 and 2026
  • Exhibits88: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits89: Overview on factors of disruption
  • Exhibits90: Impact of key risks on business
  • Exhibits91: Vendors covered
  • Exhibits92: Matrix on vendor position and classification
  • Exhibits93: Bharat Biotech Ltd. - Overview
  • Exhibits94: Bharat Biotech Ltd. - Product / Service
  • Exhibits95: Bharat Biotech Ltd. - Key news
  • Exhibits96: Bharat Biotech Ltd. - Key offerings
  • Exhibits97: CSL Ltd. - Overview
  • Exhibits98: CSL Ltd. - Business segments
  • Exhibits99: CSL Ltd. - Key news
  • Exhibits100: CSL Ltd. - Key offerings
  • Exhibits101: CSL Ltd. - Segment focus
  • Exhibits102: GlaxoSmithKline Plc - Overview
  • Exhibits103: GlaxoSmithKline Plc - Business segments
  • Exhibits104: GlaxoSmithKline Plc - Key news
  • Exhibits105: GlaxoSmithKline Plc - Key offerings
  • Exhibits106: GlaxoSmithKline Plc - Segment focus
  • Exhibits107: Merck and Co. Inc. - Overview
  • Exhibits108: Merck and Co. Inc. - Business segments
  • Exhibits109: Merck and Co. Inc. - Key news
  • Exhibits110: Merck and Co. Inc. - Key offerings
  • Exhibits111: Merck and Co. Inc. - Segment focus
  • Exhibits112: Mitsubishi Chemical Holdings Corp. - Overview
  • Exhibits113: Mitsubishi Chemical Holdings Corp. - Business segments
  • Exhibits114: Mitsubishi Chemical Holdings Corp. - Key offerings
  • Exhibits115: Mitsubishi Chemical Holdings Corp. - Segment focus
  • Exhibits116: Pfizer Inc. - Overview
  • Exhibits117: Pfizer Inc. - Product / Service
  • Exhibits118: Pfizer Inc. - Key news
  • Exhibits119: Pfizer Inc. - Key offerings
  • Exhibits120: Sanofi - Overview
  • Exhibits121: Sanofi - Business segments
  • Exhibits122: Sanofi - Key news
  • Exhibits123: Sanofi - Key offerings
  • Exhibits124: Sanofi - Segment focus
  • Exhibits125: Serum Institute of India Pvt. Ltd. - Overview
  • Exhibits126: Serum Institute of India Pvt. Ltd. - Product / Service
  • Exhibits127: Serum Institute of India Pvt. Ltd. - Key offerings
  • Exhibits128: SK Chemicals Co. Ltd. - Overview
  • Exhibits129: SK Chemicals Co. Ltd. - Business segments
  • Exhibits130: SK Chemicals Co. Ltd. - Key offerings
  • Exhibits131: SK Chemicals Co. Ltd. - Segment focus
  • Exhibits132: Takeda Pharmaceutical Co. Ltd. - Overview
  • Exhibits133: Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Exhibits134: Takeda Pharmaceutical Co. Ltd. - Key news
  • Exhibits135: Takeda Pharmaceutical Co. Ltd. - Key offerings
  • Exhibits136: Inclusions checklist
  • Exhibits137: Exclusions checklist
  • Exhibits138: Currency conversion rates for US$
  • Exhibits139: Research methodology
  • Exhibits140: Validation techniques employed for market sizing
  • Exhibits141: Information sources
  • Exhibits142: List of abbreviations